Discovery of 1,4-Substituted Piperidines as Potent and Selective Inhibitors of T-Type Calcium Channels

Citations Over TimeTop 10% of 2008 papers

Abstract

The discovery of a novel series of potent and selective T-type calcium channel antagonists is reported. Initial optimization of high-throughput screening leads afforded a 1,4-substituted piperidine amide 6 with good potency and limited selectivity over hERG and L-type channels and other off-target activities. Further SAR on reducing the basicity of the piperidine and introducing polarity led to the discovery of 3-axial fluoropiperidine 30 with a significantly improved selectivity profile. Compound 30 showed good oral bioavailability and brain penetration across species. In a rat genetic model of absence epilepsy, compound 30 demonstrated a robust reduction in the number and duration of seizures at 33 nM plasma concentration, with no cardiovascular effects at up to 5.6 microM. Compound 30 also showed good efficacy in rodent models of essential tremor and Parkinson's disease. Compound 30 thus demonstrates a wide margin between CNS and peripheral effects and is a useful tool for probing the effects of T-type calcium channel inhibition.

Related Papers

• → L-Type Calcium Channels Contribute to the Tottering Mouse Dystonic Episodes(1999)122 cited
• → Gene Therapy to Inhibit the Calcium Channel β Subunit(2007)67 cited
• → Neuroprotective effects of blockers for T-type calcium channels(2009)44 cited
• → Subunit-dependent modulation of recombinant L-type calcium channels. Molecular basis for dihydropyridine tissue selectivity.(1993)129 cited
• → Faculty Opinions recommendation of Expression of Rem2, an RGK family small GTPase, reduces N-type calcium current without affecting channel surface density.(2006)